New Key Statistics Module, Z-Score and F-Score
GREY:PLOGF Key Ratios
| Market Cap A$ M | 566.27 |
| Enterprise Value A$ M | 566.27 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 15.00 |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) A$ M | -- |
| EPS (TTM) A$ | -- |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | 1.00 |
| 5-y EBITDA Growth Rate % | -13.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -19.82 |
| EV-to-EBITDA | -20.22 |
| PEG | -- |
| Shares Outstanding M | 3,431.96 |
| Net Margin (%) | -- |
| Operating Margin % | -- |
| Pre-tax Margin (%) | -- |
| Quick Ratio | 3.99 |
| Current Ratio | 3.99 |
| ROA % (ttm) | -59.81 |
| ROE % (ttm) | -81.02 |
| ROIC % (ttm) | -447.75 |
| Dividend Yield % | -- |
| Altman Z-Score | -- |
PLOGF Number of Guru Trades
PLOGF Volume of Guru Trades
Gurus Latest Trades with GREY:PLOGF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
GREY:PLOGF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
PYC Therapeutics Ltd Insider Transactions
No Available Data
News about GREY:PLOGF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers